Why the study?
Does zatebradine block the pacemaker current I(f) in isolated rabbit sinoatrial node cells?
Does zatebradine block the pacemaker current I(f) in isolated rabbit sinoatrial node cells?
Answers are grounded in this paper and cite their sources.
Zatebradine reduces heart rate via use-dependent block of the I(f) pacemaker current, identifying it as a novel I(f) blocker.
BACKGROUND: Zatebradine (UL-FS 49) is a drug with a specific bradycardiac electrophysiological profile. It reduces heart rate by lengthening the duration of diastolic depolarization in the sinoatrial (SA) node. The ionic basis of this action, however, is not clarified. METHODS AND RESULTS: We used the whole-cell patch-clamp technique to study the effects of zatebradine on ionic currents underlying diastolic depolarization of isolated rabbit SA node cells. Low concentrations of zatebradine simultaneously reduced diastolic depolarization rate and the pacemaker current I(f). The drug blocked the pacemaker current, I(f), in a use-dependent manner without causing a shift of its activation curve. At hyperpolarized potentials, unblock of I(f) occurred. Clinically relevant concentrations of the drug have little effect on the L-type calcium current or delayed rectifier potassium current. CONCLUSIONS: This use-dependent block of the If channel can account for most of the pharmacological characteristics of zatebradine and is probably the mechanism of heart rate reduction caused by this agent. Thus, the sinus node inhibitor zatebradine belongs to a new class of "I(f) blockers" with possible advantages over currently available drugs for the treatment of ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Goethals et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: